Olfr520 Inhibitors
Olfr520, an olfactory receptor, plays a crucial role in detecting specific odorants within the olfactory system. This receptor is involved in transducing extracellular signals into intracellular responses, ultimately leading to the perception of odors. The intricate network of signaling pathways associated with Olfr520 includes the cholinergic system, cyclic nucleotide signaling, MAPK/ERK, PI3K-AKT, JNK, and mTOR pathways. Inhibition of Olfr520 involves targeted modulation of these pathways. Dichlorvos disrupts the cholinergic system, influencing Olfr520 indirectly by altering acetylcholine levels. Rolipram, a PDE4 inhibitor, modifies cAMP levels, indirectly impacting Olfr520 through cyclic nucleotide signaling pathways. SB-203580 and U0126 target MAPK pathways, altering downstream signaling and leading to changes in Olfr520 expression. Wortmannin and LY294002, PI3K inhibitors, influence Olfr520 by perturbing the PI3K-AKT pathway.
Additionally, SP600125 disrupts the JNK signaling pathway, Rapamycin affects mTOR signaling, and PD98059 targets the MAPK/ERK pathway, all indirectly influencing Olfr520. VX-745, a p38 MAPK inhibitor, modulates the MAPK pathway, and Ruxolitinib, a JAK inhibitor, impacts the JAK-STAT pathway, both leading to altered cellular responses and Olfr520 expression. PI-103, a dual PI3K/mTOR inhibitor, perturbs intracellular signaling, modifying Olfr520 gene expression. In summary, the inhibition of Olfr520 involves intricate modulation of specific biochemical and cellular pathways, ultimately influencing the receptor's expression and function within the olfactory system.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
PDE4 inhibitor altering cAMP levels. Indirectly impacts Olfr520 by modifying cyclic nucleotide signaling pathways, leading to altered gene expression patterns within the olfactory system. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor disrupting the MAPK pathway. Influences Olfr520 by inhibiting a downstream signaling component, resulting in altered cellular responses and modulation of olfactory receptor expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor affecting the PI3K-AKT pathway. Indirectly modulates Olfr520 by interfering with intracellular signaling cascades, leading to changes in gene expression and olfactory receptor regulation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor targeting the MAPK/ERK pathway. Influences Olfr520 indirectly by disrupting a key signaling cascade, leading to altered expression patterns and functional regulation of olfactory receptors. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor impacting the PI3K-AKT pathway. Indirectly influences Olfr520 by perturbing intracellular signaling, resulting in modified gene expression within the olfactory sensory neurons. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor disrupting the JNK signaling pathway. Influences Olfr520 by modulating downstream effectors, leading to altered gene expression profiles and functional changes in olfactory receptor activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor affecting the mTOR signaling pathway. Indirectly impacts Olfr520 by influencing cellular processes, resulting in altered gene expression patterns and functional modulation of olfactory receptors. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor targeting the MAPK/ERK pathway. Influences Olfr520 indirectly by disrupting key signaling events, leading to modified gene expression patterns and functional regulation of olfactory receptors. | ||||||
VX 745 | 209410-46-8 | sc-361401 sc-361401A | 10 mg 50 mg | $183.00 $842.00 | 4 | |
p38 MAPK inhibitor disrupting the MAPK pathway. Influences Olfr520 by inhibiting downstream components, leading to altered cellular responses and modulation of olfactory receptor expression. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
JAK inhibitor impacting the JAK-STAT pathway. Indirectly modulates Olfr520 by interfering with intracellular signaling cascades, resulting in changes in gene expression and olfactory receptor regulation. | ||||||